Q4

Windlas Biotech Ltd

WINDLASFY2522 May 2025

Revenue+3.9%

Net Profit+4.5%

OPM12.60%

P&L

Quarterly Consolidated

Revenue

+3.9%202.71

Expenditure

+4.5%186.82

Net Profit

+4.5%16.28

NPM 7.84%+0.3%EPS ₹7.77+4.3%

vs Q3 FY25

Informational and educational content only. Not investment advice.